Calithera Biosciences, Inc.

CALA · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$40-$115-$90-$90
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0-$1
Stock-Based Comp.$4$10$8$6
Change in WC-$7-$3-$4$4
Other Non-Cash-$1$42$2$1
Operating Cash Flow-$44-$66-$84-$79
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$57-$153
Inv. Sales/Matur.$0$8$146$142
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$8$89-$11
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$10$11$41$98
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$1$1
Financing Cash Flow$10$11$42$99
Forex Effect$0$0$0$0
Net Chg. in Cash-$34-$48$47$9
Supplemental Information
Beg. Cash$60$108$61$51
End Cash$26$60$108$61
Free Cash Flow-$44-$66-$84-$79